CRL | Charles River Laboratories International

225.49 -0.83 (-0.37%)

CRL Price Profile

Open

$226.84

CLOSE

$225.49

DAY RANGE

223.57 - 227.59

52 WEEK RANGE

203.37 - 460.21

MARKET CAP

16.19B

Trading volume

355.4K

Prev. Close

226.32

50 Day MA

360.57

Shares Outstanding

50.46M

Public Float

49.72M

Average Volume

397.11K

Beta

1.17

PEG Ratio

2.08

Shares Shorted

690.88K

% OF SHARES SHORTED

1.75%

Short Ratio

2.19

1 Year Performance

25.70%

Diluted EPS (TTM)

7.72

Q Revenue Growth

0.21

Ebitda

832.35M

Gross Profit (TTM)

1.08B

Total Cash (MRQ)

213.57M

Total Debt (MRQ)

3.17B

  • MRQ = Most Recent Quarter.
  • TTM = Trailing Twelve Months.

Charles River Laboratories International (CRL) company profile

Charles River Laboratories International Inc. (NYSE: CRL) is a contract research company that offers products and services to enable pharmaceutical and biotechnology companies, government agencies, and academic institutions to conduct research in drug development. The company also offers safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The company’s services are through the segments of Discovery and Safety Assessment and Manufacturing Solutions.

Latest CRL News

AD